Little Green Pharma Ltd - Asset Resilience Ratio
Little Green Pharma Ltd (LGP) has an Asset Resilience Ratio of 2.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check LGP PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how Little Green Pharma Ltd's Asset Resilience Ratio has changed over time. See LGP net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Little Green Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Little Green Pharma Ltd worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$2.30 Million | 2.36% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$2.30 Million | 2.36% |
Asset Resilience Insights
- Limited Liquidity: Little Green Pharma Ltd maintains only 2.36% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Little Green Pharma Ltd Industry Peers by Asset Resilience Ratio
Compare Little Green Pharma Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 11.69% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131 |
Drug Manufacturers - Specialty & Generic | 1.37% |
|
Bausch Health Companies Inc
TO:BHC |
Drug Manufacturers - Specialty & Generic | 4.97% |
|
Dezhan HealthCare Co Ltd
SHE:000813 |
Drug Manufacturers - Specialty & Generic | 0.15% |
|
Guizhou Xinbang Pharmaceutical Co Ltd
SHE:002390 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Hainan Haiyao Co Ltd
SHE:000566 |
Drug Manufacturers - Specialty & Generic | 3.27% |
|
Shanxi Zhendong Pharmaceutical
SHE:300158 |
Drug Manufacturers - Specialty & Generic | 10.74% |
Annual Asset Resilience Ratio for Little Green Pharma Ltd (2018–2025)
The table below shows the annual Asset Resilience Ratio data for Little Green Pharma Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 2.47% | AU$2.38 Million ≈ $1.68 Million |
AU$96.12 Million ≈ $68.01 Million |
-3.29pp |
| 2024-06-30 | 5.76% | AU$4.97 Million ≈ $3.52 Million |
AU$86.38 Million ≈ $61.12 Million |
-6.82pp |
| 2023-06-30 | 12.57% | AU$12.40 Million ≈ $8.77 Million |
AU$98.62 Million ≈ $69.78 Million |
-8.36pp |
| 2022-06-30 | 20.94% | AU$20.09 Million ≈ $14.21 Million |
AU$95.95 Million ≈ $67.89 Million |
-15.35pp |
| 2021-06-30 | 36.28% | AU$40.27 Million ≈ $28.49 Million |
AU$110.99 Million ≈ $78.53 Million |
+10.23pp |
| 2020-06-30 | 26.05% | AU$4.27 Million ≈ $3.02 Million |
AU$16.40 Million ≈ $11.61 Million |
+22.77pp |
| 2019-06-30 | 3.28% | AU$510.29K ≈ $361.06K |
AU$15.57 Million ≈ $11.01 Million |
-33.38pp |
| 2018-06-30 | 36.65% | AU$1.47 Million ≈ $1.04 Million |
AU$4.02 Million ≈ $2.85 Million |
-- |
About Little Green Pharma Ltd
Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.